(1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione

C33H33N3O6S2 — CID 19253185

IUPAC(1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione
SMILESCOc1ccc(N2C(=O)[C@H]3[C@H]4C[C@@H]([C@@H]3C2=O)[C@@H]2[C@H](c3ccc(OCC(=O)N5CCCCC5)cc3)c3sc(=O)[nH]c3S[C@H]42)cc1
InChIInChI=1S/C33H33N3O6S2/c1-41-19-11-7-18(8-12-19)36-31(38)26-21-15-22(27(26)32(36)39)28-25(21)24(29-30(43-28)34-33(40)44-29)17-5-9-20(10-6-17)42-16-23(37)35-13-3-2-4-14-35/h5-12,21-22,24-28H,2-4,13-16H2,1H3,(H,34,40)/t21-,22-,24+,25-,26+,27+,28-/m1/s1
InChIKeyCVJPLEGWKGHPED-FJUWNDPMSA-N
MW631.78 g/mol
LogP4.51
Rot. Bonds6

About (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione

(1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione (PubChem CID 19253185) has the molecular formula C33H33N3O6S2 and a molecular weight of 631.78 g/mol. Its IUPAC name is (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione.

Molecular Properties

Compound Name(1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione
PubChem CID19253185
Molecular FormulaC33H33N3O6S2
Molecular Weight631.78 g/mol
Exact Mass631.18
IUPAC Name(1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione
SMILESCOc1ccc(N2C(=O)[C@H]3[C@H]4C[C@@H]([C@@H]3C2=O)[C@@H]2[C@H](c3ccc(OCC(=O)N5CCCCC5)cc3)c3sc(=O)[nH]c3S[C@H]42)cc1
InChIInChI=1S/C33H33N3O6S2/c1-41-19-11-7-18(8-12-19)36-31(38)26-21-15-22(27(26)32(36)39)28-25(21)24(29-30(43-28)34-33(40)44-29)17-5-9-20(10-6-17)42-16-23(37)35-13-3-2-4-14-35/h5-12,21-22,24-28H,2-4,13-16H2,1H3,(H,34,40)/t21-,22-,24+,25-,26+,27+,28-/m1/s1
InChIKeyCVJPLEGWKGHPED-FJUWNDPMSA-N
XLogP4.51
TPSA109.01 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms44
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500631.78
LogP ≤ 54.51
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'thiaz_ene_E(8)', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione?
The IUPAC name of (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione (CID 19253185) is (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione.
What is the SMILES notation for (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione?
The canonical SMILES for (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione is COc1ccc(N2C(=O)[C@H]3[C@H]4C[C@@H]([C@@H]3C2=O)[C@@H]2[C@H](c3ccc(OCC(=O)N5CCCCC5)cc3)c3sc(=O)[nH]c3S[C@H]42)cc1.
What is the InChIKey of (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione?
The InChIKey is CVJPLEGWKGHPED-FJUWNDPMSA-N. The full InChI is InChI=1S/C33H33N3O6S2/c1-41-19-11-7-18(8-12-19)36-31(38)26-21-15-22(27(26)32(36)39)28-25(21)24(29-30(43-28)34-33(40)44-29)17-5-9-20(10-6-17)42-16-23(37)35-13-3-2-4-14-35/h5-12,21-22,24-28H,2-4,13-16H2,1H3,(H,34,40)/t21-,22-,24+,25-,26+,27+,28-/m1/s1.
What are the key properties of (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione?
(1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione has a molecular weight of 631.78 g/mol, XLogP of 4.51, 6 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2R,9R,10R,11S,12S,16R)-14-(4-methoxyphenyl)-9-[4-(2-oxo-2-piperidin-1-ylethoxy)phenyl]-3,7-dithia-5,14-diazapentacyclo[9.5.1.02,10.04,8.012,16]heptadec-4(8)-ene-6,13,15-trione is sourced from PubChem (CID 19253185), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).